- Review
- Korean J Med. 2004;67(1):137-138.
- (Epidermal growth factor receptor(EGFR) mutation strongly predicts the response to gefitinib(Iressa, ZD1839) in non-small-cell Lung Cancer)
- , , , , , , , , ,
- See Won Han, Pil Gyu Hwang, Do Youn Oh, Dong Wan Kim, Doo Hyun Chung, Seock Ah Im, Tae You Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
 |
 |
 |
 |
 |
 |